This site uses optional cookies which are currently not set, but will be if you visit another page. Find out more about the cookies we use

 
 

23May

Pharma Manufacturing Conference

Location: Partnership for Learning, South Road, Speke, Liverpool, L24 9PZ


The Bionow Pharma Manufacturing Conference is a one-day conference addressing the needs and requirements of pharma manufacturers who compete on the global stage.

The programme is being developed in conjunction with large pharma Members of Bionow to explore and address routes to efficiency, improved cost of goods, process development and the capabilities needed to exploit next generation technologies.

We are delighted to have Allergan, AstraZeneca, Elanco and Seqirus sponsoring the conference.

Through a combination of workshops, lecture and panel sessions, delegates will hear about and be able to contribute to the discussions in the key areas of:

  • Skills & Mindset - how can we do it better with a new approach
  • Next Generation Technologies
  • Steriles Manufacture
  • Innovation in Analytics
  • Regulatory Challenges and Opportunities
  • The Innovation Supply Chain

Conference Programme

Time 

Session

08.15 - 08.50 

Arrival and Registration

08.50 - 09.00

Welcome Address

Peter Timmins, Chair Health & Life Sciences Board, Liverpool City Region

09.00 - 09.30

Keynote Speaker
The Challenges in Future Pharma Manufacturing

Laura O'Brien, Vice President & Site Head, Seqirus

09.30 - 10.30

Next Generation Technologies - Gene Therapy and Viral Vaccines as a UK USP


Chair: Linda Randall, Executive Director - Biologic Development, Allergan Biologics


Paul Young, Associate Director - Process Science, Allergan Biologics
Tony Hitchcock, Technical Director, Cobra Biologics
Andrew Provan, Bioprocess Consultant, eXmoor Pharma Concepts

 

10.30 - 11.15

Coffee, Networking & Exhibition

11.15 - 12.15

Parallel Session: Steriles Manufacture

Chair: Carrie O'Keeffe, Head of Secondary Projects, Seqirus

Marsha Evans, Head of QA Operations, Ipsen
Steve Richmond, Head of Zoladex & Zomig Nasal Spray Manufacture, AstraZeneca

11.15 - 12.15

Parallel Session: Innovation in Analytics

Chair: Debbie Hogg, Team Leader Process Development Biopharmaceuticals, Elanco

Laetitia Denbigh, Application Laboratory Biopharmaceuticals Team Manager, Waters
David Spencer, Characterisation Manager, Ipsen
April Sena, Head of Technical Development, Seqirus

12.15 - 13.30

Lunch, Networking & Exhibition

13.30 - 13.45

Skills & Mindset - A Roadmap for Change

Workshop Introduction

Joanna Woolf, Chief Executive, Cogent Sector Skills Council

13.45 - 14.30

Workshop

Staff Development - Collaboration not Competition
Working together across the Northern Sites

Workshop Facilitators:
Rob Olliver, Production Team Leader, Allergan
Carrie o'Keeffe, Head of Secondary Projects, Seqirus
Debbie Hogg, Team Leader Process Development Biopharmaceuticals, Elanco

 

Delegates will be split into workshop groups for discussion

14.30 - 14.45

Workshop Feedback

Facilitators will feedback on key discussion points from the workshops

14.45- 15.45

Panel Session
How can the UK Regulatory Approach give the UK a Manufacturing Advantage?

Chair: Patrick Ginty, Head of Regulatory Affairs, Catapult Cell & Gene Therapy

 

Xiaolin Qi, Consultant Scientist - Speke Biotech Operations, Elanco
David Churchward, GMP Inspector, MHRA
Andy Jones, Founder and Director, MedrusPharma Consulting

15.45 - 16.00

Coffee, Networking & Exhibition

16.00 - 17.00

The Innovation Supply Chain: Driving World Class Capability for Tomorrow's Medicines

Chair: Richard Ryrie, Process Engineering Team Leader, Elanco

Alan Dickson, Professor of Biotechnology, University of Manchester
Marcel Kuiper, Knowledge Transfer Manager, KTN
Jon Welsh, Principal Scientist, Centre for Process Innovation (CPI)

17.00 - 17.15

Closing Remarks and Next Steps

17.15

Close


The conference will explore the challenges and enablers for bio pharma manufacturing in the North and start a conversation through which the Northern manufacturing sites begin to collaborate on areas of common interest and to better influence academia and Government industrial strategy to support manufacturing in this sector.

The UK Pharma Industry is comprised of companies engaged in research, developing, manufacturing and distributing medicines for human use. New medicines have an enormous positive influence on global health, prosperity and economic productivity by saving life, increasing life spans, and shortening hospital stays. Advances in medicine have eliminated deadly diseases and have brought other life threatening conditions under control. Drug therapy is now an integral part of every facet of healthcare and new breakthroughs continue to revolutionise the treatment of non-communicable diseases. 

The impact of the North’s life sciences sector is significant, as the private sector alone employs more than 40,000 people across 1,100 Northern life science companies (25% of the UK total). Combined these companies exported £7.3bn worth of medicinal and pharmaceutical products in 2015 equating to 44.7% of UK exports in this category (HMRC 2016). The sector is therefore vitally important to the Northern economy as well as the wider UK.

Delegate Fees
Premium Member: £125.00 + VAT
Member: £155.00 + VAT
Non-Member: £199.00 + VAT

To discuss details of sponsorship and exhibition opportunities available at the conference please contact Helen Williams at helen.williams@bionow.co.uk.

> Register here